Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 4:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1153–1176 of 1,235 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Clear all

Conditions: COVID-19
Interventions: APX-115, Placebo; Drug
Lead sponsor: Aptabio Therapeutics, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 6
States / cities: Little Rock, Arkansas • Annapolis, Maryland • Wyoming, Michigan + 3 more

Conditions: Corona Virus Infection, SARS-CoV Infection, Coronavirus
Interventions: Hydroxychloroquine, Placebo oral tablet; Drug
Lead sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: COVID-19, SARS-CoV-2 Infection
Interventions: CoTend-BXBB (SARS2-30404), CoTend-s3BXBB (SARS2-17032), Placebo; Biological
Lead sponsor: Kara Chew; Other
Eligibility: 40 Years to 64 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Los Angeles, California • San Francisco, California

Conditions: SARS-COV2, Severe Acute Respiratory Syndrome, COVID-19
Interventions: CT-V; Device
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Long COVID
Interventions: wait-list, chiropractic adjustments; Other · Procedure
Lead sponsor: Life University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Post-Acute COVID-19 Syndrome
Interventions: Baricitinib 4 MG, Placebo; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 6
States / cities: San Francisco, California • New Haven, Connecticut • Atlanta, Georgia + 2 more

Conditions: SARS-CoV-2, COVID-19
Interventions: Evusheld; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 12 Years and older
Enrollment: 5,814 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Systemic Allergic Reaction
Interventions: Pfizer-BioNTech COVID-19 Vaccine (Comirnaty), Placebo, Pfizer-BioNTech COVID-19 Vaccine, Bivalent; Biological · Other
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 16 Years to 69 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Pulmonary Fibrosis, COVID-19 Pneumonia, Long COVID
Interventions: Sirolimus; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Post-Acute COVID-19, Post-Acute COVID-19 Syndrome, Post-Acute COVID-19 Infection, Long COVID, Long Covid19, Dyspnea, Orthostasis, Cognitive Impairment
Interventions: Comprehensive Rehabilitation, Augmented Usual Care; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: Not listed
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: COVID-19
Interventions: Placebo, Remdesivir, Baricitinib; Other · Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 99 Years
Enrollment: 1,033 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 53
States / cities: Birmingham, Alabama • La Jolla, California • Los Angeles, California + 44 more

Conditions: SARS-CoV-2 Infection
Interventions: PRIME-2-CoV_Beta; Drug
Lead sponsor: Speransa Therapeutics; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 103 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 5
States / cities: Florida City, Florida • Chicago, Illinois • Kansas City, Missouri + 2 more

Conditions: Breast Ductal Carcinoma In Situ, COVID-19 Infection, Hereditary Breast Carcinoma, Invasive Breast Carcinoma
Interventions: Questionnaire Administration; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 4
States / cities: Conroe, Texas • Houston, Texas • League City, Texas + 1 more

Conditions: COVID-19, Coronavirus Infection, Coronavirus, SARS-CoV-2
Interventions: Not listed
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 18 Years and older
Enrollment: 1,316 participants
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: COVID-19, SARS-CoV-2
Interventions: Hydroxychloroquine, Placebo; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Covid-19, Subjects Vaccinated Against Covid-19
Interventions: Change in SARS-CoV-2 Antibody Levels; Other
Lead sponsor: Dr. Sidney J. Stohs; Other
Eligibility: 55 Years and older
Enrollment: 10,000 participants
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Southlake, Texas

Conditions: COVID-19
Interventions: Not listed
Lead sponsor: Randy Loftus; Other
Eligibility: 18 Years to 120 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: COVID, COVID-19, Corona Virus Infection, SARS-CoV-2
Interventions: Tear Collection; Diagnostic Test
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: COVID-19
Interventions: Nuvaxovid (NVX-CoV2705), mNEXSPIKE mRNA-1283; Drug
Lead sponsor: Marcel Curlin; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Respiratory Distress Syndrome, Adult
Interventions: agenT-797; Drug
Lead sponsor: MiNK Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 3
States / cities: Santa Monica, California • Louisville, Kentucky • New York, New York

Conditions: COVID-19
Interventions: Hydroxychloroquine, Indomethacin, Zithromax Oral Product; Drug
Lead sponsor: Perseverance Research Center, LLC; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 2
States / cities: Scottsdale, Arizona • New Orleans, Louisiana

Conditions: Cytokine Storm, SARS-CoV-2
Interventions: Doxycycline, Placebo; Drug
Lead sponsor: Temple University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: COVID-19, Acute Respiratory Failure
Interventions: COVID-19+ observational; Other
Lead sponsor: University of Vermont; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Covid-19, SARS-CoV 2, Coronavirus, COVID
Interventions: Not listed
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 201 participants
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Kansas City, Kansas

Search by objective public record fields.

A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19.

Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada)

A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses

Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2

The Impact of Chiropractic on Long COVID-19

REVERSE-Long COVID-19 With Baricitinib Study

eVusheld Assessment reaL wORld Effectiveness in the VA Health System

The Safety of Administering a Second Dose of a COVID-19 mRNA Vaccine in Individuals Who Experienced a Systemic Allergic Reaction to an Initial Dose

Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis

Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program for PASC Program to Improve Functioning of Persons Suffering From Post-COVID-19 Syndrome: A Randomized Controlled Trial

Adaptive COVID-19 Treatment Trial 2 (ACTT-2)

A Study Assessing the Safety, Tolerability, Immunogenicity of COVID-19 Vaccine Candidate PRIME-2-CoV_Beta, Orf Virus Expressing SARS-CoV_2 Spike and Nucleocapsid Proteins

Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery

St. Jude Tracking of Viral and Host Factors Associated With COVID-19

Assessing Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19)

Change in Antibody Levels Following SARS-CoV-2 (Covid-19) Vaccinations

Characterizing the Perioperative Epidemiology of SARS-CoV-2 (COVID-19) Spread for Quality Improvement of Perioperative Infection Control Program

Detecting SARS-CoV-2 in Tears

COVID-19 Reactogenicity

A Clinical Trial to Evaluate the Safety of agenT-797 in COVID-19 Participants With ARDS

Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19

RepurpoSing Old Drugs TO SuppRess a Modern Threat: COVID-19 STORM

COVID Cohort Study

COVID-19 Biorepository